|
1
|
Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection.
|
J Immunol
|
2003
|
1.56
|
|
2
|
A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.
|
J Virol
|
2005
|
1.42
|
|
3
|
Effects of promyelocytic leukemia protein on virus-host balance.
|
J Virol
|
2002
|
1.28
|
|
4
|
Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism.
|
J Virol
|
2003
|
1.25
|
|
5
|
Early blood profiles of virus infection in a monkey model for Lassa fever.
|
J Virol
|
2007
|
1.20
|
|
6
|
A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity.
|
Vaccine
|
2007
|
1.13
|
|
7
|
Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation.
|
J Virol
|
2003
|
1.10
|
|
8
|
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.
|
Vaccine
|
2008
|
1.09
|
|
9
|
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins.
|
Virology
|
2006
|
1.06
|
|
10
|
Role of the Fas/FasL pathway in HIV or SIV disease.
|
Retrovirology
|
2009
|
1.02
|
|
11
|
Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus.
|
J Med Virol
|
2002
|
1.01
|
|
12
|
Past, present, and future of arenavirus taxonomy.
|
Arch Virol
|
2015
|
1.00
|
|
13
|
Arenavirus variations due to host-specific adaptation.
|
Viruses
|
2013
|
0.99
|
|
14
|
Gene expression in primate liver during viral hemorrhagic fever.
|
Virol J
|
2009
|
0.97
|
|
15
|
HIV Tat protein increases Bcl-2 expression in monocytes which inhibits monocyte apoptosis induced by tumor necrosis factor-alpha-related apoptosis-induced ligand.
|
Intervirology
|
2007
|
0.97
|
|
16
|
Vaccinia virus inhibits T cell receptor-dependent responses by human gammadelta T cells.
|
J Infect Dis
|
2006
|
0.97
|
|
17
|
The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virus.
|
J Virol
|
2005
|
0.92
|
|
18
|
Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs.
|
Vaccine
|
2010
|
0.90
|
|
19
|
Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.
|
Antiviral Res
|
2011
|
0.88
|
|
20
|
Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses.
|
Virus Genes
|
2006
|
0.88
|
|
21
|
Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever.
|
J Med Virol
|
2004
|
0.88
|
|
22
|
An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity.
|
Virol J
|
2013
|
0.86
|
|
23
|
Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro.
|
J Virol
|
2012
|
0.86
|
|
24
|
Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidate.
|
PLoS Negl Trop Dis
|
2013
|
0.85
|
|
25
|
Circulating natural killer and gammadelta T cells decrease soon after infection of rhesus macaques with lymphocytic choriomeningitis virus.
|
Mem Inst Oswaldo Cruz
|
2009
|
0.85
|
|
26
|
Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus.
|
Blood
|
2009
|
0.84
|
|
27
|
Extracellular HIV Tat and Tat cysteine rich peptide increase CCR5 expression in monocytes.
|
J Zhejiang Univ Sci B
|
2005
|
0.79
|
|
28
|
Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model.
|
Vaccine
|
2012
|
0.79
|
|
29
|
Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virus.
|
Vaccine
|
2006
|
0.78
|
|
30
|
Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.
|
J Virol
|
2013
|
0.76
|